Nine in Ten Americans Say Always Finish the Antibiotics. The Evidence Has Moved On.

Researchers asked almost 1,500 Americans whether a course of antibiotics should always be finished, and the majority said yes ^[1]. The findings, published in Open Forum Infectious Diseases, matter because the instruction most patients are carrying around is more absolute than what the evidence now supports for many common infections ^[2].

The specific numbers are worth sitting with. Asked to agree or disagree with "Even if you start to feel better, it is important to always finish a prescribed course of antibiotics," 88 percent agreed, and three quarters of respondents said they had received that advice from a medical professional ^[3]. First author Alistair Thorpe, a research assistant professor of population health sciences at the University of Utah, told Discover the team was struck that nearly nine in ten respondents held that belief ^[4]. The belief is roughly 13 percentage points more widespread than the share who trace it to a clinician, which means it is also circulating on its own ^[1].

The survey also probed preferences. For a bacterial respiratory infection such as pneumonia, participants were asked whether they would rather have a longer course of seven or more days or a shorter one of three to five days ^[5]. About 60 percent said they would be more comfortable with the longer course ^[6]. That held across almost every demographic group, with 18- to 33-year-olds the exception, showing a slight preference for the shorter option ^[7]. The reasoning given for longer courses was essentially insurance, including one respondent who wrote that it is "better to be Safe than Sorry" and another who wanted to be sure the infection would not recur ^[8]. Those preferring shorter courses cited side effects and antibiotic resistance, and were more averse to medicines generally ^[9].

On the science, Thorpe's position is narrower than either slogan. There is no single duration right for every infection, he said, and the broad clinical direction is the shortest course that is effective for the specific infection and patient ^[10]. Appropriate duration depends on diagnosis, severity, the antibiotic used, the response to treatment, and individual risk factors ^[11]. According to Thorpe, a much larger body of evidence now shows that for many common infections appropriately selected shorter courses work just as well while reducing unnecessary exposure and side effects, with important exceptions including tuberculosis ^[12]. He also reframed the historical warning: Alexander Fleming cautioned in the 1940s that using too little of the drug could let bacteria evolve resistance ^[13], which Thorpe describes as an important point about adequate dosage rather than evidence that every patient must complete a full course ^[14]. Discover notes the BMJ has carried the argument that taking antibiotics longer than necessary could itself encourage resistance ^[15].

None of that is a licence to stop early on your own. Thorpe's instruction is to take antibiotics exactly as prescribed and speak with a clinician before stopping or changing treatment ^[16], which matches CDC guidance to follow the prescription and ask a healthcare professional about questions ^[17]. Thorpe and colleagues argue for more nuanced messaging, and he framed the shift as a chance to show how medical science works, communicating the change transparently rather than swapping one oversimplified slogan for another ^[18].

The operational point for anyone who writes prescriptions: the duration decision is now a conversation, not a default. Watch whether shorter courses arrive with an explanation of why the number of days changed, because a patient told five days with no reasoning has been handed a slogan that contradicts the one they already trust.